Hutch News
Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells
A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
.JPG)
London transplant doctors report a second person likely cured of HIV
12 years after Timothy Ray Brown was cured, we have another
Drs. Denise Galloway and Hans-Peter Kiem receive endowed chairs
Paul Stephanus Memorial Endowed Chair to Galloway; Stephanus Family Endowed Chair for Cell and Gene Therapy to Kiem
The prized fraction of Fanconi Anemia
from the Adair lab and the Kiem lab, Clinical Research Division
Dr. Geoffrey Hill 3rd recipient of José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research
Endowments provide faculty with freedom and flexibility to pursue critical research endeavors
Taking the good out of viruses to cure immunodeficiencies by in vivo gene therapy
from the Kiem lab, Clinical Research Division
One step closer to the Berlin Patient and an HIV cure
Kiem Lab, Clinical Research Division and Vaccine and Infections Disease Division
Gene editing shows promise for sickle cell and related disorders
Preclinical results offer new hope in group of dangerous inborn diseases
Dr. Reema Jain developing methods to isolate, manipulate blood stem cells for T-cell therapy
Funding from Immunotherapy Integrated Research Center supports postdoc’s work
Gene editing holds promise for shrinking HIV ‘reservoir’
Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals
A voice for HIV cure
As researchers work toward a cure, advocate Tranisha Arzah keeps the focus on community
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
New nanoparticles make targeted, temporary gene therapy possible
‘Hit-and-run’ technology could improve immunotherapy and HIV cure research
Looking for 'a multitude of ways to cure HIV'
HIV researchers draw hope from cancer immunotherapies — and inspiration from Timothy Ray Brown
Dr. Carl June weaves together HIV and cancer research to advance cures for both
CAR T-cell pioneer and one-time bone marrow transplant fellow will give keynote at HIV cure conference
6 things to know about glioblastoma
Following Sen. John McCain’s diagnosis, Fred Hutch experts offer ‘the long view’ on brain cancer research
Good News: CBS 'Sunday Morning' to feature Dr. Jim Olson's Tumor Paint research this weekend
Celebrating faculty and staff achievements
Why volunteer for an HIV cure study?
Why volunteer for an HIV cure study? A community group undertakes its own research to find out
Good News: Bezos family funding accelerates glioma immunotherapy research
Celebrating faculty and staff achievements
Good News: 5 researchers receive awards to explore immunotherapy single-cell RNA sequencing
Celebrating faculty and staff achievements
American Indians and Alaska Natives tackle HIV stigma, talk cure
American Indians and Alaska Natives tackle HIV stigma, talk cure
The Yin and Yang of transplant conditioning for an HIV cure
from the Kiem lab (Clinical Research Division)
Cake, candles and a wish for more HIV cures
An HIV workshop pays tribute to Timothy Ray Brown, whose cure 10 years ago fueled research — and hope
Happy 10th birthday, Timothy Ray Brown
<p>A decade after the first and so far only known HIV cure, researchers are hard at work to find a cure for many more</p>